• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
James Paton

Stay informed with James Paton’s coverage and analysis.

How vaccine nationalism could extend the pandemic
HealthHow vaccine nationalism could extend the pandemic
By James Paton and BloombergJanuary 31, 2021
Public health officials warn about slow vaccine rollout as coronavirus variants multiply
HealthPublic health officials warn about slow vaccine rollout as coronavirus variants multiply
By James Paton and BloombergJanuary 18, 2021
Drugmakers hit back at U.K. plan to delay the second dose of COVID vaccines
HealthDrugmakers hit back at U.K. plan to delay the second dose of COVID vaccines
By James Paton and BloombergJanuary 13, 2021
AstraZeneca acquires rare-disease specialist Alexion in $39 billion deal
HealthAstraZeneca acquires rare-disease specialist Alexion in $39 billion deal
By John Lauerman, James Paton and BloombergDecember 13, 2020
Britons will roll up their sleeves on Tuesday for a COVID vaccine jab as the world anxiously watches
HealthBritons will roll up their sleeves on Tuesday for a COVID vaccine jab as the world anxiously watches
By James Paton, Suzi Ring and BloombergDecember 7, 2020
Pfizer is developing the Covid-19 vaccine 95% effective and safe
U.K. approves Pfizer COVID-19 vaccine and will start distributing it next week
By James Paton and BloombergDecember 2, 2020
Syringe shown against the AstraZeneca logo
HealthAstraZeneca eyes another global trial for its COVID vaccine following dosage blip
By Suzi Ring, James Paton and BloombergNovember 27, 2020
Oxford says COVID-19 vaccine has produced strong immune response ahead of late-stage trial results
HealthOxford says COVID-19 vaccine has produced strong immune response ahead of late-stage trial results
By James Paton, Suzi Ring and BloombergNovember 19, 2020
AstraZeneca-Oxford COVID vaccine on track for year end, CEO Pascal Soriot says
HealthAstraZeneca-Oxford COVID vaccine on track for year end, CEO Pascal Soriot says
By Suzi Ring, James Paton and BloombergNovember 5, 2020
To jumpstart the COVID vaccine race, the U.K. considers ‘challenge trials’ exposing people to the virus
HealthTo jumpstart the COVID vaccine race, the U.K. considers ‘challenge trials’ exposing people to the virus
By James Paton and BloombergSeptember 24, 2020
Weight loss and obesity drugs could help fight COVID-19, Novo Nordisk says
HealthWeight loss and obesity drugs could help fight COVID-19, Novo Nordisk says
By James Paton and BloombergSeptember 4, 2020
A researcher wearing a face mask and gloves as a preventive
HealthThese countries aren’t waiting for a U.S., China, or U.K. COVID vaccine
By James Paton and BloombergAugust 26, 2020
U.S. pledges $2.1 billion for up to 600 million doses of Sanofi, GlaxoSmithKline vaccine
HealthU.S. pledges $2.1 billion for up to 600 million doses of Sanofi, GlaxoSmithKline vaccine
By James Paton and BloombergJuly 31, 2020
CHINA-HEALTH-VIRUS
HealthThe earliest coronavirus vaccines may not protect you from getting infected
By John Lauerman, James Paton and BloombergJune 15, 2020
France’s Sanofi to sell stake in high-flying Regeneron to fund new drugs discoveries
FinanceFrance’s Sanofi to sell stake in high-flying Regeneron to fund new drugs discoveries
By James Paton, Riley Griffin and BloombergMay 26, 2020
1
  • 1
  • 2
  • 3
3
Most Popular
Economy
'We didn’t see this coming': Wall Street eats its forecasts as stocks sell off globally on fear of AI bubble ahead of SpaceX IPOplaceholder alt text
By Jim EdwardsJune 8, 2026
Success
Gen Zers are arriving at college unable to even read a sentence—professors warn it could lead to a generation of anxious and lonely graduatesplaceholder alt text
By Preston ForeJune 7, 2026
Environment
Trump, who has repeatedly called climate change fake, is now threatening Brazil with tariffs over the deforestation of the Amazonplaceholder alt text
By Sasha RogelbergJune 8, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.